(LRN) Stride - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US86333M1080
Stock: Online Curriculum, Educational Services, Learning Software, Career Programs
Total Rating 35
Risk 82
Buy Signal -0.02
| Risk 5d forecast | |
|---|---|
| Volatility | 40.1% |
| Relative Tail Risk | -26.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.09 |
| Alpha | -29.72 |
| Character TTM | |
|---|---|
| Beta | -0.259 |
| Beta Downside | 1.375 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.07% |
| CAGR/Max DD | 0.47 |
EPS (Earnings per Share)
Revenue
Description: LRN Stride March 05, 2026
Stride, Inc. (LRN) offers online education solutions. The company provides curriculum, software, and services to support virtual and blended learning environments. This business model is common in the education technology sector, which has seen increased adoption of digital learning tools.
Stride serves K-12 students with core academic subjects and offers career learning programs. These programs prepare students for specific industries like IT and healthcare. Stride also operates tuition-based private schools and provides post-secondary career training for adult learners, including skills for software engineering and medical fields. The companys diverse offerings span public and private schools, school districts, and direct consumer markets. Investors may find it useful to compare Strides growth trajectory against other education service providers.
Headlines to watch out for
- Enrollment growth in online learning programs boosts revenue
- Government funding for virtual education impacts profitability
- Competition from traditional schools pressures market share
- Adult career learning program demand drives growth
- Regulatory changes in online education sector pose risk
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 318.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -3.45 > 1.0 |
| NWC/Revenue: 54.79% < 20% (prev 52.79%; Δ 2.00% < -1%) |
| CFO/TA 0.11 > 3% & CFO 261.6m > Net Income 318.9m |
| Net Debt (69.7m) to EBITDA (546.7m): 0.13 < 3 |
| Current Ratio: 7.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (48.3m) vs 12m ago 1.69% < -2% |
| Gross Margin: 39.30% > 18% (prev 0.39%; Δ 3.89k% > 0.5%) |
| Asset Turnover: 115.1% > 50% (prev 105.9%; Δ 9.18% > 0%) |
| Interest Coverage Ratio: 37.58 > 6 (EBITDA TTM 546.7m / Interest Expense TTM 11.4m) |
Altman Z'' 8.08
| A: 0.60 (Total Current Assets 1.60b - Total Current Liabilities 220.1m) / Total Assets 2.31b |
| B: 0.44 (Retained Earnings 1.01b / Total Assets 2.31b) |
| C: 0.20 (EBIT TTM 427.3m / Avg Total Assets 2.19b) |
| D: 1.34 (Book Value of Equity 1.01b / Total Liabilities 758.7m) |
| Altman-Z'' Score: 8.08 = AAA |
Beneish M -2.68
| DSRI: 1.30 (Receivables 869.0m/582.5m, Revenue 2.52b/2.19b) |
| GMI: 0.98 (GM 39.30% / 38.54%) |
| AQI: 0.97 (AQ_t 0.26 / AQ_t-1 0.27) |
| SGI: 1.15 (Revenue 2.52b / 2.19b) |
| TATA: 0.02 (NI 318.9m - CFO 261.6m) / TA 2.31b) |
| Beneish M-Score: -2.68 (Cap -4..+1) = A |
What is the price of LRN shares?
As of March 16, 2026, the stock is trading at USD 84.36 with a total of 458,348 shares traded.
Over the past week, the price has changed by -1.11%, over one month by +0.69%, over three months by +32.00% and over the past year by -30.81%.
Over the past week, the price has changed by -1.11%, over one month by +0.69%, over three months by +32.00% and over the past year by -30.81%.
Is LRN a buy, sell or hold?
Stride has received a consensus analysts rating of 4.17.
Therefore, it is recommended to buy LRN.
- StrongBuy: 2
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LRN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 106.3 | 26% |
| Analysts Target Price | 106.3 | 26% |
LRN Fundamental Data Overview March 14, 2026
P/E Trailing = 12.8802
P/E Forward = 9.4251
P/S = 1.4598
P/B = 2.3449
P/EG = 0.4715
Revenue TTM = 2.52b USD
EBIT TTM = 427.3m USD
EBITDA TTM = 546.7m USD
Long Term Debt = 417.2m USD (from longTermDebt, last quarter)
Short Term Debt = 62.5m USD (from shortTermDebt, last quarter)
Debt = 566.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 69.7m USD (from netDebt column, last quarter)
Enterprise Value = 3.75b USD (3.68b + Debt 566.8m - CCE 497.1m)
Interest Coverage Ratio = 37.58 (Ebit TTM 427.3m / Interest Expense TTM 11.4m)
EV/FCF = 17.87x (Enterprise Value 3.75b / FCF TTM 209.7m)
FCF Yield = 5.60% (FCF TTM 209.7m / Enterprise Value 3.75b)
FCF Margin = 8.33% (FCF TTM 209.7m / Revenue TTM 2.52b)
Net Margin = 12.66% (Net Income TTM 318.9m / Revenue TTM 2.52b)
Gross Margin = 39.30% ((Revenue TTM 2.52b - Cost of Revenue TTM 1.53b) / Revenue TTM)
Gross Margin QoQ = 41.13% (prev 39.00%)
Tobins Q-Ratio = 1.62 (Enterprise Value 3.75b / Total Assets 2.31b)
Interest Expense / Debt = 0.50% (Interest Expense 2.81m / Debt 566.8m)
Taxrate = 25.45% (34.0m / 133.4m)
NOPAT = 318.6m (EBIT 427.3m * (1 - 25.45%))
Current Ratio = 7.27 (Total Current Assets 1.60b / Total Current Liabilities 220.1m)
Debt / Equity = 0.37 (Debt 566.8m / totalStockholderEquity, last quarter 1.55b)
Debt / EBITDA = 0.13 (Net Debt 69.7m / EBITDA 546.7m)
Debt / FCF = 0.33 (Net Debt 69.7m / FCF TTM 209.7m)
Total Stockholder Equity = 1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.57% (Net Income 318.9m / Total Assets 2.31b)
RoE = 21.36% (Net Income TTM 318.9m / Total Stockholder Equity 1.49b)
RoCE = 22.37% (EBIT 427.3m / Capital Employed (Equity 1.49b + L.T.Debt 417.2m))
RoIC = 16.68% (NOPAT 318.6m / Invested Capital 1.91b)
WACC = 4.35% (E(3.68b)/V(4.24b) * Re(4.96%) + D(566.8m)/V(4.24b) * Rd(0.50%) * (1-Tc(0.25)))
Discount Rate = 4.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 5.38%
[DCF] Terminal Value 88.43% ; FCFF base≈229.8m ; Y1≈283.4m ; Y5≈482.7m
[DCF] Fair Price = 328.5 (EV 14.06b - Net Debt 69.7m = Equity 13.99b / Shares 42.6m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 64.78 | EPS CAGR: 27.01% | SUE: 0.66 | # QB: 0
Revenue Correlation: 97.74 | Revenue CAGR: 11.36% | SUE: 0.23 | # QB: 0
EPS current Year (2026-06-30): EPS=8.33 | Chg7d=+0.000 | Chg30d=+0.032 | Revisions Net=+1 | Growth EPS=+2.9% | Growth Revenue=+5.1%
EPS next Year (2027-06-30): EPS=9.08 | Chg7d=+0.000 | Chg30d=+0.120 | Revisions Net=-1 | Growth EPS=+9.0% | Growth Revenue=+4.8%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 0.2% (Discount Rate 7.9% - Earnings Yield 7.8%)
[Growth] Growth Spread = +4.6% (Analyst 4.8% - Implied 0.2%)
P/E Forward = 9.4251
P/S = 1.4598
P/B = 2.3449
P/EG = 0.4715
Revenue TTM = 2.52b USD
EBIT TTM = 427.3m USD
EBITDA TTM = 546.7m USD
Long Term Debt = 417.2m USD (from longTermDebt, last quarter)
Short Term Debt = 62.5m USD (from shortTermDebt, last quarter)
Debt = 566.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 69.7m USD (from netDebt column, last quarter)
Enterprise Value = 3.75b USD (3.68b + Debt 566.8m - CCE 497.1m)
Interest Coverage Ratio = 37.58 (Ebit TTM 427.3m / Interest Expense TTM 11.4m)
EV/FCF = 17.87x (Enterprise Value 3.75b / FCF TTM 209.7m)
FCF Yield = 5.60% (FCF TTM 209.7m / Enterprise Value 3.75b)
FCF Margin = 8.33% (FCF TTM 209.7m / Revenue TTM 2.52b)
Net Margin = 12.66% (Net Income TTM 318.9m / Revenue TTM 2.52b)
Gross Margin = 39.30% ((Revenue TTM 2.52b - Cost of Revenue TTM 1.53b) / Revenue TTM)
Gross Margin QoQ = 41.13% (prev 39.00%)
Tobins Q-Ratio = 1.62 (Enterprise Value 3.75b / Total Assets 2.31b)
Interest Expense / Debt = 0.50% (Interest Expense 2.81m / Debt 566.8m)
Taxrate = 25.45% (34.0m / 133.4m)
NOPAT = 318.6m (EBIT 427.3m * (1 - 25.45%))
Current Ratio = 7.27 (Total Current Assets 1.60b / Total Current Liabilities 220.1m)
Debt / Equity = 0.37 (Debt 566.8m / totalStockholderEquity, last quarter 1.55b)
Debt / EBITDA = 0.13 (Net Debt 69.7m / EBITDA 546.7m)
Debt / FCF = 0.33 (Net Debt 69.7m / FCF TTM 209.7m)
Total Stockholder Equity = 1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.57% (Net Income 318.9m / Total Assets 2.31b)
RoE = 21.36% (Net Income TTM 318.9m / Total Stockholder Equity 1.49b)
RoCE = 22.37% (EBIT 427.3m / Capital Employed (Equity 1.49b + L.T.Debt 417.2m))
RoIC = 16.68% (NOPAT 318.6m / Invested Capital 1.91b)
WACC = 4.35% (E(3.68b)/V(4.24b) * Re(4.96%) + D(566.8m)/V(4.24b) * Rd(0.50%) * (1-Tc(0.25)))
Discount Rate = 4.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 5.38%
[DCF] Terminal Value 88.43% ; FCFF base≈229.8m ; Y1≈283.4m ; Y5≈482.7m
[DCF] Fair Price = 328.5 (EV 14.06b - Net Debt 69.7m = Equity 13.99b / Shares 42.6m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 64.78 | EPS CAGR: 27.01% | SUE: 0.66 | # QB: 0
Revenue Correlation: 97.74 | Revenue CAGR: 11.36% | SUE: 0.23 | # QB: 0
EPS current Year (2026-06-30): EPS=8.33 | Chg7d=+0.000 | Chg30d=+0.032 | Revisions Net=+1 | Growth EPS=+2.9% | Growth Revenue=+5.1%
EPS next Year (2027-06-30): EPS=9.08 | Chg7d=+0.000 | Chg30d=+0.120 | Revisions Net=-1 | Growth EPS=+9.0% | Growth Revenue=+4.8%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 0.2% (Discount Rate 7.9% - Earnings Yield 7.8%)
[Growth] Growth Spread = +4.6% (Analyst 4.8% - Implied 0.2%)